Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Guggenheim analyst Debjit Chattopadhyay initiated coverage on Entrada Therapeutics Inc (NASDAQ:TRDA) with a Buy rating and announced a price target of $20. Entrada Therapeutics shares closed at $10.82 on Tuesday. See how other analysts view this stock.
- Stifel analyst Laura Prendergast initiated coverage on BridgeBio Oncology Therapeutics, Inc. (NASDAQ:BBOT) with a Buy rating and announced a price target of $23. BridgeBio Oncology shares closed at $10.84 on Tuesday. See how other analysts view this stock.
- Goldman Sachs analyst Brian Lee initiated coverage on Energy Fuels Inc. (AMEX:UUUU) with a Buy rating and announced a price target of $30. Energy Fuels shares closed at $21.76 on Tuesday. See how other analysts view this stock.
- Stifel analyst Laura Prendergast initiated coverage on Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) with a Buy rating and announced a price target of $48. Olema Pharmaceuticals shares closed at $23.37 on Tuesday. See how other analysts view this stock.
Considering buying OLMA stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments